PharmSync
ActiveSummary
PharmSync has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €104,589 and a net result of €57,846. Its solvency ranks better than 78% of 11425 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78
Track record82
Bankruptcy probability, 12 months
1.3%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8,000 at 30 days only on tighter terms
Liquidity ample (current ratio 4.25 against 5.2 in 2024; short-term debt: 23.5% and cash: 85.7% of total assets), and 23.5% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
76.5%
Return on assets
42.3%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filingsDeviation from the deadline
2025
31 d late
2024
2 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 2 accounts on average 15 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
26-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Roughly what is this company worth?Value indication
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€104,589▲ 124%
2024 · €46,743
Total assets
€136,689▲ 137%
2024 · €57,767
Net result
€57,846▲ 32.2%
2024 · €43,743
Working capital
€104,189▲ 125%
2024 · €46,343
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20242025
Operating result€57,605-€75,161▲ 30.5%
Net result€43,743-€57,846▲ 32.2%
Equity€46,743-€104,589▲ 124%
Total assets€57,767-€136,689▲ 137%
Debt€11,024-€32,100▲ 191%
Working capital€46,343-€104,189▲ 125%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result rises in 2025; 2025 is 30% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €136,689
Fixed assets
€400 =
Current assets
€136,289 ▲ 138%
Equity and liabilities €136,689
Equity
€104,589 ▲ 124%
Debt
€32,100 ▲ 191%
Debt's share of the balance-sheet total rises from 19.1% to 23.5%. Equity and debt are higher.
Key figures and ratios
Current ratio
4.25▼
2024 · 5.20
Debt to equity
0.31▲
2024 · 0.24
ROE
55.3%▼
2024 · 93.6%
ROA
42.3%▼
2024 · 75.7%
Debt ≤ 1 year
€32,100▲
2024 · €11,024
Income taxes
€15,922▲
2024 · €12,789
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Other operating charges640/8 | €118 | €386 | ▲ 227% |
| Gross operating margin9900 | €57,723 | €75,547 | ▲ 30.9% |
| Operating profit (loss)9901 | €57,605 | €75,161 | ▲ 30.5% |
| Financial income75/76B | €0 | €85 | ▲ 284,100% |
| Recurring financial income75 | €0 | €85 | ▲ 284,100% |
| Financial charges65/66B | €1,073 | €1,478 | ▲ 37.8% |
| Recurring financial charges65 | €1,073 | €1,478 | ▲ 37.8% |
| Profit (loss) for the period before taxes9903 | €56,532 | €73,768 | ▲ 30.5% |
| Income taxes67/77 | €12,789 | €15,922 | ▲ 24.5% |
| Profit (loss) for the period9904 | €43,743 | €57,846 | ▲ 32.2% |
| Profit (loss) for the period to be appropriated9905 | €43,743 | €57,846 | ▲ 32.2% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €57,767 | €136,689 | ▲ 137% |
| Fixed assets21/28 | €400 | €400 | = |
| Financial fixed assets28 | €400 | €400 | = |
| Current assets29/58 | €57,367 | €136,289 | ▲ 138% |
| Amounts receivable within one year40/41 | €2,239 | €19,046 | ▲ 751% |
| Trade receivables40 | €2,113 | €18,920 | ▲ 795% |
| Other amounts receivable41 | €126 | €126 | = |
| Cash at bank and in hand54/58 | €54,668 | €117,092 | ▲ 114% |
| Deferred charges and accrued income490/1 | €460 | €152 | ▼ 67.1% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €57,767 | €136,689 | ▲ 137% |
| Equity10/15 | €46,743 | €104,589 | ▲ 124% |
| Contributions10/11 | €3,000 | €3,000 | = |
| Profit (loss) carried forward14 | €43,743 | €101,589 | ▲ 132% |
| Amounts payable17/49 | €11,024 | €32,100 | ▲ 191% |
| Amounts payable within one year42/48 | €11,024 | €32,100 | ▲ 191% |
| Trade debts44 | €963 | €22,715 | ▲ 2,260% |
| Suppliers440/4 | €963 | €22,715 | ▲ 2,260% |
| Taxes, remuneration and social security45 | €9,877 | €9,221 | ▼ 6.6% |
| Taxes450/3 | €9,877 | €9,221 | ▼ 6.6% |
| Other amounts payable47/48 | €184 | €164 | ▼ 10.9% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €43,743 | €57,846 | ▲ 32.2% |
| Operating cash flow (approximation) | €43,743 | €57,846 | ▲ 32.2% |
| Investment in fixed assets (approximation) | - | €0 | - |
| Change in cash | - | €62,424 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Equity above €100,000Eq €104,589 ▲124%
2 profitable years in a row build equity to €104,589.
29-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2023
Ground area
674 m²
Building footprint
241 m²
Volume, LiDAR
3,534 m³
Parcel 11463D0447/00P000, Flanders · tallest building 17.2 m, ±5 floors. Linked by address, not a title deed.
4
companies at this address
See who is registered here
1 establishment unit
PharmSync
since 20232.353.816.054
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11463D0447/00P000 | Flanders | 674 m² | 1 · 240 m² | 17.2 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
VetPlus BE
BE 0750.737.933
Dentergem · Eq €103,735
ECCE MEDICAL
BE 0767.377.787
Scherpenheuvel-Zichem · Eq €106,630
MEDA BRIGHT
BE 0705.993.912
Brussel · Eq €106,648
HCPS
BE 0606.991.851
Antwerpen · Eq €102,554
ENDOVISION
BE 0444.953.351
Holsbeek · Eq €102,431
Of 1,902 companies in sector 46460 we hold annual accounts for 1,116. 620 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded13-12-2023
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
Scores and ratios are computed by Checked and are not a credit decision.